Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Androgen receptors help prostate cancer cells grow and resist drugs.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Analog 23 is a promising compound for prostate cancer treatment.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Pumpkin seed products may help improve prostate and bladder health by blocking certain enzymes and hormone receptors.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Geranylgeraniol from nutmeg may effectively treat hair loss, similar to finasteride and better than minoxidil.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Clascoterone may be a promising treatment for hair loss.